RICK HUMMEL: Open Payments
NPI 1609955483 · ST LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,357 in 108 payments from 23 companies in 2025. Trend: 2023 $1,796 · 2024 $1,820 · 2025 $2,357
Food & beverage: $2,349Education: $8
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 18 | $554 |
| AstraZeneca Pharmaceuticals LP | 11 | $213 |
| Lilly USA, LLC | 11 | $198 |
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $153 |
| Novo Nordisk Inc | 7 | $148 |
| Kowa Pharmaceuticals America, Inc. | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Paratek Pharmaceuticals, Inc. | 4 | $91 |
Products named: EPIDIOLEX, AIRSUPRA, REXULTI, MOUNJARO, CAPLYTA, ZORYVE, TRELEGY ELLIPTA, NUZYRA.
Industry payments across MO — which companies pay providers there.
